Experience

MannKind to Acquire scPharmaceuticals for up to $360 Million

August 25, 2025

Cooley advised MannKind Corporation (Nasdaq: MNKD), a company focused on the development and commercialization of inhaled therapeutic products and delivery devices for patients with endocrine and orphan lung diseases, on its definitive merger agreement to acquire scPharmaceuticals for up to $360 million

Read more

Related contacts

Barbara Borden
Senior Counsel, San Diego
Rowook Park
Partner, San Diego
Julia Kim
Special Counsel, New York
Mischi a Marca
Partner, San Francisco
Adam J. Longenbach
Partner, New York
Matthew S. Scarano
Associate, San Diego
Megan Browdie
Partner, Washington, DC
Ross Eberly
Partner, Santa Monica
Todd Gluth
Partner, San Diego
Eric Greig
Partner, Washington, DC
Asa Henin
Partner, San Diego
Phil Mitchell
Partner, New York
Alessandra Murata
Partner, Palo Alto
Stella Sarma
Partner, Brussels
Charity Williams
Partner, San Diego
Julia R. Brinton
Special Counsel, Washington, DC
Andrew Epstein
Special Counsel, Seattle
Emily Mason
Special Counsel, Santa Monica
Randy Sabett
Special Counsel, Washington, DC
Natasha Leskovsek
Of Counsel, Washington, DC
David Dalton
Associate, Santa Monica
Sharon Davidov
Associate, New York
Jameson Davis
Associate, Boston
Athina Gaki
Associate, Brussels
Tony P. Guan
Associate, Santa Monica
Josh Himmelstern
Associate, San Diego
Michelle Hunt
Associate
Wyatt Kernell
Associate, Colorado
Bomin Kim
Associate, New York
Allison Kutner
Associate, New York
Jacob R. Lahana
Associate, Santa Monica
Eileen Leman
Associate, Los Angeles
Walter Musgrave
Associate, San Diego
Joseph Perry
Associate, Reston
Allie Pilmer
Associate, San Diego
Breanna Qin
Associate, Palo Alto
Vittoria Rainone
Associate, San Diego
Bartholomäus Regenhardt
Associate, Brussels
Brittany K. Wightman
Associate, San Diego
Jennifer Fitzpatrick
Paralegal Specialist, Washington, DC

Related Practices & Industries

Cooley Advises Investor Syndicate on $2.25 Billion Acquisition of HistoSonics

August 7, 2025

Cooley advised a syndicate of globally recognized private and public investors in connection with the management-led majority stake acquisition of HistoSonics, the developer of the Edison Histotripsy System and novel histotripsy therapy platform, valuing the company at approximately $2.25 billion.

Read more

Related contacts

Patrick Loofbourrow
Partner, Singapore
Bram G. Couvreur
Partner, Santa Monica
Rama Padmanabhan
Partner, San Diego
Jenny Ge
Associate, Santa Monica
Nick Kenyon
Associate, Boston
Josh Himmelstern
Associate, San Diego
Joanna Zhang
Associate, San Diego
Megan Browdie
Partner, Washington, DC
Sharon Connaughton
Special Counsel, Washington, DC
Stephanie Gentile
Partner, New York
Alessandra Murata
Partner, Palo Alto
Mark Cornillez-Ty
Associate, Los Angeles
Michael Pelle
Associate, New York
Orion Armon
Partner, Colorado
Alexis Finkelberg Bortniker
Partner, San Diego
Ross Eberly
Partner, Santa Monica
Charles Haley
Partner, Palo Alto
Joanna Liebes Hubberts
Partner, San Diego
Christopher Kimball
Partner, Washington, DC
John Paul Oleksiuk
Partner, New York
Stella Sarma
Partner, Brussels
Ellie Seber
Partner, Santa Monica
Erin Trenda
Partner, San Diego
Charity Williams
Partner, San Diego
Mark Windfeld-Hansen
Senior Counsel, Palo Alto
Bryan Berman
Special Counsel, Colorado
Andrew Epstein
Special Counsel, Seattle
Robert Jacques
Special Counsel, Washington, DC
Christian Lee
Special Counsel, San Francisco
Son Nguyen
Special Counsel, Washington, DC
Karen Tsai
Special Counsel, Washington, DC
Stefan Cohen
Associate, New York
Sharon Davidov
Associate, New York
Jameson Davis
Associate, Boston
Michael Fernando
Associate, London
Allison Kutner
Associate, New York
Alexandra Leavy
Associate, New York
Eileen Leman
Associate, Los Angeles
Sunny J. Levine
Associate, Colorado
Edward (Teddy) Nimetz
Associate, New York
Emma Plankey
Associate, Boston
Breanna Qin
Associate, Palo Alto
Shu-en Wee
Associate, Singapore
Asal Yunusov
Associate, New York
Lisa Amii
Patent Agent, Palo Alto
Anna Anderson
Paralegal Specialist, London
Patricia Myers
Paralegal Specialist, Colorado
Gayana Stokes
Senior Paralegal, Washington, DC
Katie Kissner
Quantitative Analyst, San Francisco
Daniel Grooms
Partner, Washington, DC

Related Practices & Industries

Y-mAbs Therapeutics Agrees to Acquisition by SERB Pharmaceuticals

August 5, 2025

Cooley advised Y-mAbs Therapeutics, a commercial-stage biopharmaceutical company focused on the development and commercialization of antibody-based therapeutics for the treatment of cancer, on its definitive merger agreement with SERB Pharmaceuticals. Under the agreement, SERB will acquire Y-mAbs, including its lead commercial oncology asset, DANYELZA, in an all-cash transaction representing an equity value of approximately $412 million.

Read more

Related contacts

Bill Sorabella
Partner, New York
Bill Roegge
Partner, New York
Div Gupta
Partner, New York
Sarah Sellers
Partner, New York
Christophe Beauduin
Partner, New York
Megan Browdie
Partner, Washington, DC
Brad Goldberg
Partner, New York
Christopher Kimball
Partner, Washington, DC
Eileen Marshall
Partner, Washington, DC
Darah Protas
Partner, Washington, DC
Natasha Leskovsek
Of Counsel, Washington, DC
Julia Kim
Special Counsel, New York
Justin Kisner
Special Counsel, San Diego
MaryBeth Shreiner
Special Counsel, Reston
Karen Tsai
Special Counsel, Washington, DC
Amanda Weiss
Special Counsel, New York
Rajdeep Roger Bains
Associate, San Diego
Dayne Brown
Associate, New York
Norma Chayo Dichi
Associate, Washington, DC
Sharon Davidov
Associate, New York
Athina Gaki
Associate, Brussels
Kyle Hess
Associate, New York
Katie Kaufman
Associate, Boston
Nicollette R. Kirby
Associate, Washington, DC
Christopher Nickas
Associate, New York
Arda Can Tekin
Associate, New York
Shaun (Tianjie) Wang
Associate, New York

Related Practices & Industries

Cooley Represents 3SBio on Antitrust Aspects of Its Exclusive Licensing Agreement With Pfizer

July 24, 2025

Cooley advised 3SBio, a leading Chinese biopharmaceutical company, on antitrust aspects of its up to $6 billion+ exclusive licensing agreement with Pfizer for the development, manufacture and commercialization of SSGJ-707, a bispecific antibody targeting programmed cell death protein 1 (PD-1) and vascular endothelial growth factor (VEGF).

Read more

Related contacts

David Burns
Special Counsel, Washington, DC
Megan Browdie
Partner, Washington, DC
Rubin Waranch
Associate, Colorado

Related Practices & Industries

Lovable Secures $200 Million Series A

July 17, 2025

Read more

Related contacts

Kevin Rooney
Partner, San Francisco
Karem M. Jarada
Associate, San Francisco
Carl Min
Associate, San Francisco
Chu Lee
Paralegal Specialist, San Francisco
Megan Browdie
Partner, Washington, DC
John Paul Oleksiuk
Partner, New York
Mark Windfeld-Hansen
Senior Counsel, Palo Alto
Julia R. Brinton
Special Counsel, Washington, DC
David Dalton
Associate, Santa Monica
Jake Ironfield
Transactional Quantitative Analyst, New York
Brian Mitchell
Transactional Quantitative Analyst, San Diego

Related Practices & Industries

View more

Admissions and credentials

District of Columbia

New York

Rankings and accolades

Chambers USA: Antitrust – District of Columbia (2022 – 2025)

The Legal 500 US: Merger Control (2024 – 2025)

National Law Journal: DC Rising Star

ABA Top 40 Young Lawyer Award

Super Lawyers Rising Stars: Antitrust

Best Lawyers: Antitrust Law, Ones to Watch

Who's Who Legal: Competition - Future Leader